Abingdon Health Plc (AIM:ABDX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 8.00
-0.75 (-8.57%)
Nov 12, 2026, 3:28 PM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 34.81 million as of November 12, 2026. It is the 30,478th most valuable company in the world and the 674th biggest in the United Kingdom. Its market cap has increased by 2.96% in one year.
Market Cap
34.81M
Enterprise Value
33.28M
Revenue
10.99M
Global Rank
Country Rank
#674 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 34.81M, a decrease of -65.53%. That is a compound annual growth rate of -16.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 36.98M | 33.33% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.53B |
| GSK plc | 75.61B |
| Haleon | 29.82B |
| Smith & Nephew | 9.67B |
| Hemogenyx Pharmaceuticals | 42.16M |
| BATM Advanced Communications | 38.43M |
| Shield Therapeutics | 35.31M |
| Arecor Therapeutics | 35.11M |